erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson's disease models. (PubMed, J Biomed Sci) - Sep 6, 2024 - "The potential of PEV-based therapies in neuroprotection opens new therapeutic avenues for neurodegenerative disorders. The study advocates for clinical trials to establish the efficacy of PEV-based biotherapies in neuroregenerative medicine." 
Journal • CNS Disorders • Inflammation • Movement Disorders • Parkinson's Disease • Vascular Neurology
http://www.ncbi.nlm.nih.gov/pubmed/39237980
 
David Blum; David Devos; Deng-Yao Lee; Kelly Timmerman; Liling Delila; Luc Buee; Ming-Li Chou; Nhi Thao Ngoc Le; Ouada Nebie; Szu-Yi Chou; Thierry Burnouf; Yu-Wen Wu
 
Sep 6, 2024
 
Prev Next